Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Myron Levin to Chickenpox Vaccine

This is a "connection" page, showing publications Myron Levin has written about Chickenpox Vaccine.

 
Connection Strength
  
 
 
3.889
  
  1. Weinberg A, Lazar AA, Zerbe GO, Hayward AR, Chan IS, Vessey R, Silber JL, MacGregor RR, Chan K, Gershon AA, Levin MJ. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. J Infect Dis. 2010 Apr 01; 201(7):1024-30.
    View in: PubMed
    Score: 0.334
  2. Levin MJ, DeBiasi RL, Bostik V, Schmid DS. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis. 2008 Nov 15; 198(10):1444-7.
    View in: PubMed
    Score: 0.304
  3. Levin MJ. Varicella vaccination of immunocompromised children. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S200-6.
    View in: PubMed
    Score: 0.289
  4. Johnson R, McElhaney J, Pedalino B, Levin M. Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis. 2007 Nov; 11 Suppl 2:S43-8.
    View in: PubMed
    Score: 0.283
  5. Levin MJ, Schmader K. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity. Herpes. 2007 Sep; 14 Suppl 2:45-7.
    View in: PubMed
    Score: 0.280
  6. Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis. 2006 Jul 15; 194(2):247-55.
    View in: PubMed
    Score: 0.257
  7. Weinberg A, Horslen SP, Kaufman SS, Jesser R, Devoll-Zabrocki A, Fleckten BL, Kochanowicz S, Seipel KR, Levin MJ. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant. 2006 Mar; 6(3):565-8.
    View in: PubMed
    Score: 0.252
  8. Ellison MC, Zerbe GO, Levin MJ. Responder cell frequency estimation and binomial three-level nonlinear mixed effects model in limiting dilution assays. J Biopharm Stat. 2005; 15(1):165-78.
    View in: PubMed
    Score: 0.232
  9. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis. 2003 Oct 01; 188(7):954-9.
    View in: PubMed
    Score: 0.213
  10. Levin MJ, Weinberg A. Immune Responses to Varicella-Zoster Virus Vaccines. Curr Top Microbiol Immunol. 2023; 438:223-246.
    View in: PubMed
    Score: 0.202
  11. Levin MJ. Use of varicella vaccines to prevent herpes zoster in older individuals. Arch Virol Suppl. 2001; (17):151-60.
    View in: PubMed
    Score: 0.176
  12. Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, Stinson D, Zerbe GO, Hayward AR. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis. 1998 Nov; 178 Suppl 1:S109-12.
    View in: PubMed
    Score: 0.152
  13. Reisinger KS, Richardson E, Malacaman EA, Levin MJ, Gardner JL, Wang W, Stek JE, Kuter B. A double-blind, randomized, controlled, multi-center safety and immunogenicity study of a refrigerator-stable formulation of VARIVAX?. Vaccine. 2019 09 10; 37(38):5788-5795.
    View in: PubMed
    Score: 0.150
  14. Levin MJ, Hayward AR. The varicella vaccine. Prevention of herpes zoster. Infect Dis Clin North Am. 1996 Sep; 10(3):657-75.
    View in: PubMed
    Score: 0.130
  15. Weinberg A, Levin MJ, Macgregor RR. Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults. Hum Vaccin. 2010 Apr; 6(4):318-21.
    View in: PubMed
    Score: 0.084
  16. Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol. 2009 Jul; 81(7):1310-22.
    View in: PubMed
    Score: 0.079
  17. Gershon AA, Levin MJ, Weinberg A, Song LY, LaRussa PS, Steinberg SP, Bartlett P. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella. Pediatr Infect Dis J. 2009 Jul; 28(7):653-5.
    View in: PubMed
    Score: 0.079
  18. Gershon AA, Arvin AM, Levin MJ, Seward JF, Schmid DS. Varicella vaccine in the United States: a decade of prevention and the way forward. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S39-40.
    View in: PubMed
    Score: 0.072
  19. Loparev VN, Rubtcova E, Seward JF, Levin MJ, Schmid DS. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis. 2007 Feb 15; 195(4):502-10.
    View in: PubMed
    Score: 0.067
  20. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 02; 352(22):2271-84.
    View in: PubMed
    Score: 0.060
  21. Smith JG, Levin M, Vessey R, Chan IS, Hayward AR, Liu X, Kaufhold RM, Clair J, Chalikonda I, Chan C, Bernard M, Wang WW, Keller P, Caulfield MJ. Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization. J Med Virol. 2003; 70 Suppl 1:S38-41.
    View in: PubMed
    Score: 0.051
  22. Buda K, Tubergen DG, Levin MJ. The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1996 May; 18(2):106-12.
    View in: PubMed
    Score: 0.032
  23. Levin MJ. Can herpes zoster be prevented? Eur J Clin Microbiol Infect Dis. 1996 Jan; 15(1):1-3.
    View in: PubMed
    Score: 0.031
  24. Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis. 1994 Sep; 170(3):522-6.
    View in: PubMed
    Score: 0.028
  25. Somekh E, Levin MJ. Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine. J Med Virol. 1993 Jul; 40(3):241-3.
    View in: PubMed
    Score: 0.026
  26. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis. 1992 Aug; 166(2):253-9.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)